| Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... European journal of preventive cardiology 26 (8), 824-835, 2019 | 787 | 2019 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 303 | 2019 |
| Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme … K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... European journal of preventive cardiology 28 (4), 370-379, 2021 | 147 | 2021 |
| Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV—a … V Gyberg, D De Bacquer, K Kotseva, G De Backer, O Schnell, J Sundvall, ... European heart journal 36 (19), 1171-1177, 2015 | 122 | 2015 |
| EUROASPIRE Investigators*. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology … K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... Eur J Prev Cardiol 26 (8), 824-835, 2019 | 80 | 2019 |
| Association of cardio-ankle vascular index with cardiovascular risk factors and cardiovascular events in metabolic syndrome patients A Laucevičius, L Ryliškytė, J Balsytė, J Badarienė, R Puronaitė, ... Medicina 51 (3), 152-158, 2015 | 58 | 2015 |
| Efficacy and safety of PCSK9 inhibition with evolocumab in reducing cardiovascular events in patients with metabolic syndrome receiving statin therapy: secondary analysis from … P Deedwania, SA Murphy, A Scheen, J Badariene, AL Pineda, ... JAMA cardiology 6 (2), 139-147, 2021 | 57 | 2021 |
| Lithuanian High Cardiovascular Risk (LitHiR) primary prevention programme-rationale and design A Laucevicius, V Kasiulevicius, D Jatuzis, Z Petrulioniene, L Ryliskyte, ... Semin. Cardiovasc. Med 18 (3), 2012 | 47 | 2012 |
| Systemic assessment of arterial wall structure and function in metabolic syndrome M Kovaite, Z Petrulioniene, L Ryliskyte, J Badariene, V Dzenkeviciute, ... PROCEEDINGS-WESTERN PHARMACOLOGY SOCIETY 50, 123, 2007 | 40 | 2007 |
| Aerobic training effect on arterial stiffness in metabolic syndrome I Slivovskaja, L Ryliskyte, P Serpytis, R Navickas, J Badarienė, ... The American journal of medicine 131 (2), 148-155, 2018 | 27 | 2018 |
| The fact not to ignore: Mean blood pressure is the main predictor of increased arterial stiffness in patients with systemic rheumatic diseases A Čypienė, J Dadonienė, D Miltinienė, E Rinkūnienė, R Rugienė, ... Advances in medical sciences 62 (2), 223-229, 2017 | 23 | 2017 |
| The relationship between the metabolic syndrome and arterial wall thickness: A mosaic still to be interpreted A Scuteri, OH Franco, AG Majiid, B Jolita, B Sergey, HM Cheng, CH Chen, ... Atherosclerosis 255, 11-16, 2016 | 22 | 2016 |
| High-risk profile in a region with extremely elevated cardiovascular mortality A Laucevičius, E Rinkūnienė, V Skorniakov, Ž Petrulionienė, ... Hellenic J Cardiol 54 (6), 441-7, 2013 | 22 | 2013 |
| Vitamin D, cardiovascular and bone health in postmenopausal women with metabolic syndrome J Dadonienė, A Čypienė, E Rinkūnienė, J Badarienė, A Laucevičius Advances in clinical and experimental medicine 27 (11), 1555-1560, 2018 | 21 | 2018 |
| Lietuvos didelės kardiovaskulinės rizikos pacientų atrankos ir prevencinių premonių (LitHiR) programos rezultatai: dislipidemijos paplitimas tarp vidurinio amžiaus suaugusių … E Rinkūnienė, A Laucevičius, Ž Petrulionienė, J Badarienė Medicinos teorija ir praktika 18 (4.2), 636-42, 2012 | 20 | 2012 |
| Association of aortic stiffness, carotid intima-media thickness and endothelial function with cardiovascular events in metabolic syndrome subjects L Ryliškytė, R Navickas, P Šerpytis, R Puronaitė, J Zupkauskienė, ... Blood Pressure 28 (2), 131-138, 2019 | 18 | 2019 |
| Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines J Kubica, P Adamski, P Niezgoda, D Alexopoulos, J Badarienė, A Budaj, ... Cardiology journal 27 (6), 661-676, 2020 | 16 | 2020 |
| Predictive models for type 2 diabetes onset in middle-aged subjects with the metabolic syndrome M Ozery-Flato, N Parush, T El-Hay, Ž Visockienė, L Ryliškytė, J Badarienė, ... Diabetology & metabolic syndrome 5, 1-9, 2013 | 15 | 2013 |
| Aortic stiffness is an independent determinant of left ventricular diastolic dysfunction in metabolic syndrome patients S Solovjova, L Ryliškytė, J Čelutkienė, J Badarienė, R Navickas, ... Blood Pressure 25 (1), 11-20, 2016 | 14 | 2016 |
| The prevalence of erectile dysfunction and its association with cardiovascular risk factors in patients after myocardial infarction E Rinkūnienė, S Gimžauskaitė, J Badarienė, V Dženkevičiūtė, M Kovaitė, ... Medicina 57 (10), 1103, 2021 | 13 | 2021 |
